Bank7 Corp.
For the period ended Sep 30, 2025. Filed Nov 7, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 7, 2025
BSVN$59.18+0.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unaudited Condensed Consolidated Statements of Shareholders’ Equity
Statements of Shareholders’ Equity
(Dollar amounts in thousands, except share and per share data)
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Common Stock (Shares) | ||||
| Balance at beginning of period | 9,449,319 | 9,253,038 | 9,390,211 | 9,197,696 |
| Exercise of employee stock options | 1,250 | 87,819 | 9,313 | 106,820 |
| Shares issued for restricted stock units | 1,625 | 625 | 76,088 | 52,261 |
| Shares acquired and retired | (215) | (215) | (23,633) | (15,510) |
| Balance at end of period | 9,451,979 | 9,341,267 | 9,451,979 | 9,341,267 |
| Common Stock (Amount) | ||||
| Balance at beginning of period | $94 | $93 | $94 | $92 |
| Net shares purchased and retired for restricted stock units and issued for stock options | 1 | - | 1 | 1 |
| Balance at end of period | $95 | $93 | $95 | $93 |
| Additional Paid-in Capital | ||||
| Balance at beginning of period | $102,321 | $98,570 | $101,809 | $97,417 |
| Shares purchased and retired for restricted stock units | (9) | (7) | (1,026) | (425) |
| Exercise of stock options | 30 | 1,576 | 145 | 1,906 |
| Stock-based compensation expense | 842 | 621 | 2,256 | 1,862 |
| Balance at end of period | $103,184 | $100,760 | $103,184 | $100,760 |
| Retained Earnings | ||||
| Balance at beginning of period | $133,186 | $97,891 | $116,281 | $78,962 |
| Net income | 10,844 | 11,777 | 32,285 | 34,589 |
| Cash dividends declared ($0.27 and $0.24 per share for the three months ended September 30, 2025 and 2024, respectively; $0.75 and $0.66 per share for the nine months ended September 30, 2025 and 2024, respectively) | (2,552) | (2,242) | (7,088) | (6,125) |
| Balance at end of period | $141,478 | $107,426 | $141,478 | $107,426 |
| Accumulated Other Comprehensive Loss | ||||
| Balance at beginning of period | $(3,742) | $(5,748) | $(4,971) | $(6,145) |
| Comprehensive income | 721 | 1,631 | 1,950 | 2,028 |
| Balance at end of period | $(3,021) | $(4,117) | $(3,021) | $(4,117) |
| Total Shareholders' equity | $241,736 | $204,162 | $241,736 | $204,162 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.